@GregCarney

Pharmacoepidemiologist with the Therapeutics Initiative, @UBC. PhD in Pharmacology. Partner at Wildlife Intel. #epitwitter #RxEpi #MachineLearning

 British Columbia, Canada
ti.ubc.ca/
Joined June 2009
  • Tweets153
  • Following902
  • Followers921
18Media
New research exploring the complexity of #diabetes prescribing in BC Highlights *⬇️baseline A1C values * Alarming⬇️1st-line metformin * SU remains 2nd-line favorite #DiabetesAwarenessMonth Treatment pattern trends of medications for type 2 diabetes drc.bmj.com/content/10/6/e00…
2
3
10
Nearly 30% of older adults with type 2 diabetes in BC may be overtreated, despite already having A1C ≤7%. Our new study uses machine learning + clinical expertise to identify who’s most at risk. #Diabetes #Deprescribing @Drug_Evidence bmjopen.bmj.com/content/16/3…

Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type...

Objective To estimate the prevalence of potential overtreatment of type 2 diabetes mellitus (T2DM) among older adults and to develop and compare predictive models to identify patient and physician...

bmjopen.bmj.com
1
2
386
Greg Carney retweeted
Jesús Palacio@je_pala7 Oct 2025
Obstáculos y facilitadores para reducir la solicitud innecesaria de analíticas de hormonas tiroideas qualitysafety.bmj.com/conten… en @BMJ_Qual_Saf #SegPac
4
3
323
Our @drug_evidence team has worked so hard on Portraits ti.ubc.ca/portrait/ and we have RCT evidence that it improves #prescribing patterns. How excited, grateful, & proud we feel to be recognized by @UBC Medicine for our innovation in #CME med.ubc.ca/news/faculty-of-m…
1
1
7
871
🆕 Barriers and facilitators to appropriate thyroid function testing: a provincial mixed-methods study ebm.bmj.com/content/30/Suppl… #labtesting #overdiagnosis #MedEd
1
3
198
10,200 BC patients took Paxlovid. Nearly half had side effects. Most mild - some serious and ending in hospital care. Here's what we found: tinyurl.com/5n8uun98

Patient‐Reported Adverse Drug Events on Nirmatrelvir–Ritonavir: A Prospective Observational Study...

Background There is a paucity of population-based data on adherence and adverse drug events (ADEs) associated with the treatment of coronavirus disease 2019 (COVID-19) with nirmatrelvir and ritonav...

accpjournals.onlinelibrary.wiley.com
42
Greg Carney retweeted
Brad Langford@BRxAD12 Jan 2025
Peer comparison audit & feedback works to improve antibiotic prescribing in primary care. Now, health system leaders and policy-makers must take decisive steps to integrate this strategy into the healthcare system. doi.org/10.1136/bmjqs-2024-0… 🆕@BMJ_Qual_Saf 👏@DrKevinSchwartz
2
6
15
970
Results are in! The UBC Therapeutics Initiative operates one of the most innovative Audit & Feedback programs in the world. You can check it out here: ti.ubc.ca/portrait/ qualitysafety.bmj.com/conten…
1
77
🆕UBC TI Therapeutics Letter 1⃣4⃣6⃣: #Apixaban is safer and more effective than rivaroxaban for non-valvular atrial fibrillation 👉🏽ti.ubc.ca/letter146 #MedEd #medsafety #prescribing #DOACs #NVAF
9
26
2,492
Prescription ranitidine use in 6 Canadian provinces. Among younger adults prevalence was lowest in BC. Across all 6 provinces, females more commonly dispensed an H2RA. cmajopen.ca/content/11/6/E10…

Prescription ranitidine use and population exposure in 6 Canadian provinces, 1996 to 2019: a serial...

Background:Ranitidine was the most prescribed histamine-2 receptor antagonist (H2RA) in Canada when recalled in 2019 because of potential carcinogenicity. We sought to compare geographic and temporal...

cmajopen.ca
1
1
1,775
Treatment of adult ADHD has increased over 1600% since 2004! #ADHD @Drug_Evidence theglobeandmail.com/canada/a…

B.C. seeing surge in stimulant drugs being prescribed for adult ADHD, letter says

Data compiled by the University of B.C.’s Therapeutics Initiative shows ADHD medication use climbed gradually during the 2010s and then increased considerably during the COVID-19 pandemic

theglobeandmail.com
2
1
4
158
@Drug_Evidence
1
60
🧵How should we diagnose & manage adult attention deficit hyperactivity disorder (ADHD)? 1/ Our UBC TI Therapeutics Letter 144 examines the evidence for pharmacotherapy and non-drug treatments for adult #ADHD 👉🏽ti.ubc.ca/letter144 #MedEd #MedTwitter #diagnosis #prescribing
1
11
1
22
5,147
We @Drug_Evidence did a thing. Because getting your prescribing feedback along with the latest evidence = best care for British Columbians! thischangedmypractice.com/im… #TCMPed #feedback @BCFamilyDoctors @BCCFP @UBCCPD shout out to @PathwaysBC @HDCBC_Canada @DoctorsOfBC FPSC+ more!
3
6
680
🚨 Calling all BC #FamilyDoctors + #NPs 🩺 Improve pt care with distilled evidence + #prescribing feedback💊 = UBC Therapeutics Initiative Portraits Register online by Oct 14 & you'll be entered to win an iPad! Register: secure.ti.ubc.ca/register.ph… Info: ti.ubc.ca/portrait
1
2
347
That’s a wrap at #icpe2023 where I presented 3 research posters from the UBC Therapeutics Initiative @Drug_Evidence. #Paxlovid effectiveness, +results from our highly successful Prescriber Portrait program. The scientific program this year was second to none!
1
307
🆕 #Prescribing Portraits publication! 🚨 Trial finds personalized prescribing feedback to family physicians + population data on antibiotic resistance, with a simple therapeutic recommendation, can significantly improve prescribing of #antibiotics 👉🏽journals.plos.org/plosone/ar…
5
1
7
2,283
Multi-site population-based cohort study finds HCTZ not associated with an overall increased risk of keratinocyte carcinoma compared with ACEIs or CCBs, although increased risks were observed with longer durations 👉🏽jaad.org/article/S0190-9622(… #medsafety #prescribing
3
5
1,123
UBC TI Therapeutics Letter 1⃣4⃣1⃣ : #Paxlovid in BC 🔴Efficacy evidence from unvaxxed high-risk pts in 2021 may be irrelevant to pts in 2023 🟡Benefits unproven in lower-risk #COVID19 pts 🟢Evidence of some benefit in high-risk groups in BC during 2022 ti.ubc.ca/letter141
4
4
1,151
Check out our @YouTube channel to view our #MedEd, #BetterPrescribing & #PatientExperience videos 🤩🧑🏾‍💻 👉🏽Watch+Subscribe: youtube.com/@drug_evidence #BetterHealth #Prescribing #MedTwitter #FOAMed #Deprescribing #ResearchMethods
5
6
733
🆕 UBC TI Therapeutics Letter 1⃣4⃣1⃣ : #Paxlovid in BC 🔴Efficacy evidence from unvaxxed high-risk pts in 2021 may be irrelevant to pts in 2023 🟡Benefits unproven in lower-risk #COVID19 pts 🟢Evidence of some benefit in high-risk BC groups during 2022 ti.ubc.ca/letter141
1
9
2
6
5,198
Load more